Search

  1. Head of Biomarkers

    Vacancy

    … USA. ProQR is focused on the development of life changing RNA therapies to meet the unmet need of individuals and … of the communities we serve. Our proprietary Axiomer® RNA editing technology platform enables the editing of …

  2. Junior HR Business Partner

    Vacancy

    … USA. ProQR is focused on the development of life changing RNA therapies to meet the unmet need of individuals and … of the communities we serve. Our proprietary Axiomer® RNA editing technology platform enables the editing of …

  3. Head of Clinical Quantitative Science

    Vacancy

    … USA. ProQR is focused on the development of life changing RNA therapies to meet the unmet need of individuals and … of the communities we serve. Our proprietary Axiomer® RNA editing technology platform enables the editing of …

  4. Pharmacokinetic and Pharmacodynamic Modelling Expert

    Vacancy

    … USA. ProQR is focused on the development of life changing RNA therapies to meet the unmet need of individuals and … of the communities we serve. Our proprietary Axiomer® RNA editing technology platform enables the editing of …

  5. Principal Scientist Liver

    Vacancy

    … USA. ProQR is focused on the development of life changing RNA therapies to meet the unmet need of individuals and … of the communities we serve. Our proprietary Axiomer® RNA editing technology platform enables the editing of …

  6. ProQR update and additional sepofarsen Illuminate trial analyses

    News update

    ProQR has announced the completion of an in-depth strategic review designed to deliver on our commitment to advance RNA therapies for diseases with high unmet need. We are also sharing additional analyses of the sepofarsen Illuminate trial.

    ProQR logo on the left. The word update on the right.

  7. ProQR Analyst Event

    Webcast

    During this webcast ProQR leadership will highlight key advancements from its clinical-stage pipeline and Axiomer® RNA editing platform.

  8. American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

    Congress

    ProQR will present new preclinical data for Axiomer, including the first preclinical data for its AX-0810 pipeline program for cholestatic diseases targeting NTCP at the ASGCT Annual Meeting, May 7-11, 2024, in Baltimore, Maryland.